155 related articles for article (PubMed ID: 14746841)
1. Specific gene expression and therapy for pancreatic cancer using the cytosine deaminase gene directed by the rat insulin promoter.
Wang XP; Yazawa K; Yang J; Kohn D; Fisher WE; Brunicardi FC
J Gastrointest Surg; 2004 Jan; 8(1):98-108; discussion 106-8. PubMed ID: 14746841
[TBL] [Abstract][Full Text] [Related]
2. Suicide gene therapy with the yeast fusion gene cytosine deaminase/uracil phosphoribosyltransferase is not enough for pancreatic cancer.
Fogar P; Navaglia F; Basso D; Greco E; Zambon CF; Fadi E; Falda A; Stranges A; Vannozzi F; Danesi R; Pedrazzoli S; Plebani M
Pancreas; 2007 Oct; 35(3):224-31. PubMed ID: 17895842
[TBL] [Abstract][Full Text] [Related]
3. Specific targeting of pancreatic islet cells in vivo by insulin-promoter-driven adenoviral conjugated reporter genes.
Wang X; Olmsted-Davis E; Davis A; Liu S; Li Z; Yang J; Brunicardi FC
World J Surg; 2006 Aug; 30(8):1543-52. PubMed ID: 16855800
[TBL] [Abstract][Full Text] [Related]
4. Nerve growth factor exerts differential effects on the growth of human pancreatic cancer cells.
Zhu ZW; Friess H; Wang L; Bogardus T; Korc M; Kleeff J; Büchler MW
Clin Cancer Res; 2001 Jan; 7(1):105-12. PubMed ID: 11205897
[TBL] [Abstract][Full Text] [Related]
5. Combination of cytosine deaminase suicide gene expression with DR5 antibody treatment increases cancer cell cytotoxicity.
Kaliberov SA; Chiz S; Kaliberova LN; Krendelchtchikova V; Della Manna D; Zhou T; Buchsbaum DJ
Cancer Gene Ther; 2006 Feb; 13(2):203-14. PubMed ID: 16082379
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of a gene-directed enzyme-product therapy (GDEPT) in human pancreatic tumor cells and their use as in vivo models for pancreatic cancer.
Hlavaty J; Petznek H; Holzmüller H; Url A; Jandl G; Berger A; Salmons B; Günzburg WH; Renner M
PLoS One; 2012; 7(7):e40611. PubMed ID: 22815775
[TBL] [Abstract][Full Text] [Related]
7. Cell-specific cytotoxicity of human pancreatic adenocarcinoma cells using rat insulin promoter thymidine kinase-directed gene therapy.
Tirone TA; Wang XP; Templeton NS; Lee T; Nguyen L; Fisher W; Brunicardi FC
World J Surg; 2004 Aug; 28(8):826-33. PubMed ID: 15457366
[TBL] [Abstract][Full Text] [Related]
8. A novel synthetic human insulin super promoter for targeting PDX-1-expressing pancreatic cancer.
Liu SH; Yu J; Sanchez R; Liu X; Heidt D; Willey J; Nemunaitis J; Brunicardi FC
Cancer Lett; 2018 Apr; 418():75-83. PubMed ID: 29309817
[TBL] [Abstract][Full Text] [Related]
9. [MiR-150-5p inhibits the proliferation and promoted apoptosis of pancreatic cancer cells].
Sun Y; Jin XL; Zhang TT; Jia CW; Chen J
Zhonghua Bing Li Xue Za Zhi; 2013 Jul; 42(7):460-4. PubMed ID: 24246865
[TBL] [Abstract][Full Text] [Related]
10. Insulinoma-induced hypoglycemic death in mice is prevented with beta cell-specific gene therapy.
Tirone TA; Fagan SP; Templeton NS; Wang X; Brunicardi FC
Ann Surg; 2001 May; 233(5):603-11. PubMed ID: 11323498
[TBL] [Abstract][Full Text] [Related]
11. Treatment of human tumor cells by combine gene therapy harnessing plasmids expressing human tumor necrosis factor alpha and bacterial cytosine deaminase suicide gene.
Pastorakova A; Hlubinova K; Altaner C
Neoplasma; 2006; 53(6):478-84. PubMed ID: 17167715
[TBL] [Abstract][Full Text] [Related]
12. Enhanced cytotoxicity of RIPTK gene therapy of pancreatic cancer via PDX-1 co-delivery.
Liu S; Wang XP; Brunicardi FC
J Surg Res; 2007 Jan; 137(1):1-9. PubMed ID: 17161985
[TBL] [Abstract][Full Text] [Related]
13. Combined suicide gene therapy for pancreatic peritoneal carcinomatosis using BGTC liposomes.
Hajri A; Wack S; Lehn P; Vigneron JP; Lehn JM; Marescaux J; Aprahamian M
Cancer Gene Ther; 2004 Jan; 11(1):16-27. PubMed ID: 14681723
[TBL] [Abstract][Full Text] [Related]
14. Berberine diminishes side population and down-regulates stem cell-associated genes in the pancreatic cancer cell lines PANC-1 and MIA PaCa-2.
Park SH; Sung JH; Chung N
Mol Cell Biochem; 2014 Sep; 394(1-2):209-15. PubMed ID: 24894821
[TBL] [Abstract][Full Text] [Related]
15. [In vitro treatment of ovarian cancer cells with cytosine deaminase-thymidine kinase fusion disuicide gene therapy system under the control of human telomerase reverse transcriptase gene promoter].
Kong BH; Song Y; Ma DX; Qu X; Jiang S
Zhonghua Fu Chan Ke Za Zhi; 2004 Jun; 39(6):390-5. PubMed ID: 15312323
[TBL] [Abstract][Full Text] [Related]
16. Numb/Notch signaling pathway modulation enhances human pancreatic cancer cell radiosensitivity.
Bi YL; Min M; Shen W; Liu Y
Tumour Biol; 2016 Nov; 37(11):15145-15155. PubMed ID: 27677287
[TBL] [Abstract][Full Text] [Related]
17. Pancreatic tumor mass in a xenograft mouse model is decreased by treatment with therapeutic stem cells following introduction of therapeutic genes.
Kim DJ; Yi BR; Lee HR; Kim SU; Choi KC
Oncol Rep; 2013 Sep; 30(3):1129-36. PubMed ID: 23807450
[TBL] [Abstract][Full Text] [Related]
18. Gene therapy of pancreatic cancer with green fluorescent protein and tumor necrosis factor-related apoptosis-inducing ligand fusion gene expression driven by a human telomerase reverse transcriptase promoter.
Katz MH; Spivack DE; Takimoto S; Fang B; Burton DW; Moossa AR; Hoffman RM; Bouvet M
Ann Surg Oncol; 2003 Aug; 10(7):762-72. PubMed ID: 12900367
[TBL] [Abstract][Full Text] [Related]
19. Increased tumorigenicity in the human pancreatic cell line MIA PaCa-2 is associated with an aberrant regulation of an IGF-1 autocrine loop and lack of expression of the TGF-beta type RII receptor.
Freeman JW; Mattingly CA; Strodel WE
J Cell Physiol; 1995 Oct; 165(1):155-63. PubMed ID: 7559796
[TBL] [Abstract][Full Text] [Related]
20. Molecular chemotherapy of pancreatic cancer using novel mutant bacterial cytosine deaminase gene.
Kaliberova LN; Della Manna DL; Krendelchtchikova V; Black ME; Buchsbaum DJ; Kaliberov SA
Mol Cancer Ther; 2008 Sep; 7(9):2845-54. PubMed ID: 18790765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
